Stem cell-derived extracellular vesicles as immunomodulatory agents: targeting pathological crosstalk in systemic lupus erythematosus and multiple sclerosis
Yao L., Li Q., Peng W., Sun A., Li S., Zou M.
Narrative Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Med (Lausanne) (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42221115
- PMCID
- PMC13215942
- DOI
- 10.3389/fmed.2026.1796038
Abstract (original English)
Systemic lupus erythematosus (SLE) and multiple sclerosis (MS) are chronic immune-mediated diseases characterized by overlapping clinical presentations and shared immunoregulatory pathways. Both conditions involve dysregulated immune cell activation, autoantibody production, cytokine imbalance, compromised blood-brain barrier (BBB), and mechanisms that establish self-perpetuating cycles that drive neuroinflammatory cascades, demyelination, and tissue injury. Stem cell-derived extracellular vesicles (SC-EVs) efficiently deliver and protect bioactive cargo, notably key immunoregulatory molecules including microRNAs (miRNAs) and proteins, from enzymatic degradation through their bilayer membrane structure, facilitating intercellular communication and immune modulation. Preclinical studies in animal models of SLE and experimental autoimmune encephalomyelitis (EAE, the standard MS model) have demonstrated that mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) modulate immune responses by suppressing pro-inflammatory mediators, enhancing anti-inflammatory signaling, promoting tissue repair, and conferring neuroprotection. Accumulating evidence suggests that the functional cargo of MSC-EVs targets key pathogenic processes in both diseases, including immune cell polarization, cytokine regulation, and tissue regeneration. This review examines the convergent immunomodulatory
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level ASystematic ReviewEurope PMC
Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies
Systematic Review on Neuroinflammation, Skin Aging, published in Cureus (2026) — summary generated from the PubMed abstract.
- 2026
Cureus - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level ASystematic ReviewEurope PMC
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
Systematic Review with a reported sample of 123 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Biologics (2026) — summary generated from the PubMed abstract.
- 2026
- n = 123
Biologics